JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1994) 140, 171-177    DOI: 10.1677/joe.0.1400171
© 1994 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujinaga, H
Right arrow Articles by Nakano, R
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fujinaga, H
Right arrow Articles by Nakano, R

FSH and LH up-regulate epidermal growth factor receptors in rat granulosa cells

H Fujinaga, M Yamoto, T Shikone and R Nakano

Epidermal growth factor (EGF) modulates ovarian folliculogenesis and steroidogenesis and its binding sites have been demonstrated in the ovary. We investigated the localization of EGF-binding sites in the rat ovary, and the effects of FSH and LH on EGF binding to cultured granulosa cells. Autoradiographic localization of 125I-labelled mouse EGF-binding sites was demonstrated in the granulosa and luteal cells. Displacement study and Scatchard analysis showed that a single class of specific binding sites for 125I-labelled mouse EGF was present in the granulosa cells, obtained from the ovaries of immature rats treated with diethylstilboesterol. The number of binding sites and the apparent dissociation constant were 4336 binding sites/cell and 3·42 pmol/l respectively. The granulosa cells were cultured for 48 h at 37 °C in medium alone or with increasing amounts of ovine FSH (oFSH; 1–1000 µg/l). FSH treatment increased 125I-labelled mouse EGF binding to the granulosa cells in a dose-dependent manner. After culture with oFSH (100 µg/l) for 48 h, the cells were cultured in medium alone or with increasing amounts of ovine LH (oLH; 1–1000 µg/l) for an additional 48 h. LH treatment also increased 125I-labelled mouse EGF binding in a dose-dependent manner, compared with the control. However, neither FSH nor LH altered receptor-binding affinity. Furthermore, after culture with oFSH (FSH-primed) or oFSH followed by oLH (LH-primed), tissue plasminogen activator (tPA) activities in the conditioned media were examined by fibrin autography. FSH-primed or LH-primed granulosa cells were more responsive to EGF action to induce an increase in tPA activity. In conclusion, it is suggested that functional receptors for EGF in rat granulosa cells are up-regulated by FSH and LH.

Journal of Endocrinology (1994) 140, 171–177




This article has been cited by other articles:


Home page
ReproductionHome page
I Demeestere, J Centner, C Gervy, Y Englert, and A Delbaere
Impact of various endocrine and paracrine factors on in vitro culture of preantral follicles in rodents
Reproduction, August 1, 2005; 130(2): 147 - 156.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C K Leung
Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells
Endocr. Relat. Cancer, June 1, 2005; 12(2): 407 - 421.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Martoriati, G. Duchamp, and N. Gerard
In Vivo Effect of Epidermal Growth Factor, Interleukin-1{beta}, and Interleukin-1RA on Equine Preovulatory Follicles
Biol Reprod, May 1, 2003; 68(5): 1748 - 1754.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. Prochazka, P. Kalab, and E. Nagyova
Epidermal Growth Factor-Receptor Tyrosine Kinase Activity Regulates Expansion of Porcine Oocyte-Cumulus Cell Complexes In Vitro
Biol Reprod, March 1, 2003; 68(3): 797 - 803.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.